• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Improved mechanical reliability of the HeartMate XVE left ventricular assist system.

作者信息

Pagani Francis D, Long James W, Dembitsky Walter P, Joyce Lyle D, Miller Leslie W

机构信息

Section of Cardiac Surgery, University of Michigan Health System, Ann Arbor, Michigan 48109, USA.

出版信息

Ann Thorac Surg. 2006 Oct;82(4):1413-8. doi: 10.1016/j.athoracsur.2006.04.057.

DOI:10.1016/j.athoracsur.2006.04.057
PMID:16996944
Abstract

BACKGROUND

The HeartMate XVE left ventricular assist device is a valuable treatment option for patients with end-stage heart failure. During the past several years, the XVE has undergone a series of design enhancements to improve reliability. We compared the reliability of the two most recent design iterations of the XVE pump (stitch modification to the inflow valve assembly and new inflow valve housing redesign) to the earlier VE version.

METHODS

A retrospective evaluation of device reliability was performed for 268 devices implanted in 245 patients (VE: n = 167 devices, 147 patients, implant dates October 16, 1998, to December 19, 2003; XVE: n = 101 devices, 98 patients, implant dates August 1, 2002, to April 14, 2004).

RESULTS

Median duration of device support for the VE and XVE was 159 days (range, 0 to 1,206 days) and 229 days (range, 0 to 693 days), respectively (p = 0.495). Significantly fewer major device malfunctions occurred within the XVE group as compared with the VE group (6 versus 36, respectively; p = 0.0003). The number of major device malfunctions per patient-year of support for inflow valve dysfunction, bearing wear, and other failures for the VE and XVE were 0.2 versus 0.04 (p = 0.006), 0.16 versus 0.01 (p = 0.005), and 0.06 versus 0.04 (p = 1.000), respectively. The freedom from major device malfunction at 1 year was 76% +/- 6% for the VE and 97% +/- 2% for the XVE device (p < 0.001). The freedom from death as a result of major device malfunction at 1 year was 97% +/- 2% for the VE and 98% +/- 2% for the XVE (p = 0.698).

CONCLUSIONS

Design enhancements to the HeartMate XVE have significantly reduced the incidence of major device malfunctions compared with the earlier VE model because of a reduction in failure modes from bearing wear and inlet valve dysfunction. Further follow-up is necessary to establish the long-term durability of the most recent XVE pump version.

摘要

相似文献

1
Improved mechanical reliability of the HeartMate XVE left ventricular assist system.
Ann Thorac Surg. 2006 Oct;82(4):1413-8. doi: 10.1016/j.athoracsur.2006.04.057.
2
HeartMate VE LVAS design enhancements and its impact on device reliability.HeartMate VE左心室辅助系统的设计改进及其对设备可靠性的影响。
Eur J Cardiothorac Surg. 2004 Jun;25(6):958-63. doi: 10.1016/j.ejcts.2004.03.003.
3
Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year.HeartMate XVE左心室辅助装置耐久性的提高可提供长达1年的安全机械支持,但在第二年与装置故障的高风险相关。
J Heart Lung Transplant. 2006 Apr;25(4):384-90. doi: 10.1016/j.healun.2005.11.437.
4
Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.正中胸骨切开术与肋下切口用于将HeartMate XVE心室辅助装置更换为HeartMate II心室辅助装置的临床经验。
Ann Thorac Surg. 2008 May;85(5):1646-9. doi: 10.1016/j.athoracsur.2008.01.020.
5
Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.使用HeartMate II左心室辅助装置作为桥接至移植治疗可提高生存率并降低不良事件发生率。
Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.
6
Identification of device malfunction in patients supported with the HeartMate XVE left ventricular assist system.使用HeartMate XVE左心室辅助系统支持的患者中设备故障的识别。
ASAIO J. 2007 May-Jun;53(3):298-303. doi: 10.1097/MAT.0b013e318033a6b0.
7
Improving outcomes with long-term "destination" therapy using left ventricular assist devices.使用左心室辅助装置进行长期“目标”治疗以改善治疗效果。
J Thorac Cardiovasc Surg. 2008 Jun;135(6):1353-60; discussion 1360-1. doi: 10.1016/j.jtcvs.2006.09.124.
8
Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.左心室辅助装置植入术后的右心功能障碍:搏动性HeartMate I与轴流式HeartMate II装置的比较
Ann Thorac Surg. 2008 Sep;86(3):832-40; discussion 832-40. doi: 10.1016/j.athoracsur.2008.05.016.
9
Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.离心式、轴流式和搏动式左心室辅助装置支持对心力衰竭患者终末器官功能的影响。
J Heart Lung Transplant. 2009 Apr;28(4):352-9. doi: 10.1016/j.healun.2009.01.005.
10
Exchange techniques for implantable ventricular assist devices.
ASAIO J. 2008 Jan-Feb;54(1):14-9. doi: 10.1097/MAT.0b013e318161d705.

引用本文的文献

1
Fluid-structure interaction modelling of a positive-displacement Total Artificial Heart.容积式全人工心脏的流固耦合建模
Sci Rep. 2023 Apr 14;13(1):5734. doi: 10.1038/s41598-023-32141-2.
2
Mechanical Circulatory Support for Advanced Heart Failure: Are We about to Witness a New "Gold Standard"?晚期心力衰竭的机械循环支持:我们即将见证一种新的“金标准”吗?
J Cardiovasc Dev Dis. 2016 Dec 12;3(4):35. doi: 10.3390/jcdd3040035.
3
Physiologic effects of continuous-flow left ventricular assist devices.连续流左心室辅助装置的生理效应
J Surg Res. 2016 May 15;202(2):363-71. doi: 10.1016/j.jss.2016.01.015. Epub 2016 Jan 20.
4
Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004-2011.2004 - 2011年医疗保险受益人群中左心室辅助装置的使用趋势及治疗结果
Open Heart. 2014 Aug 5;1(1):e000109. doi: 10.1136/openhrt-2014-000109. eCollection 2014.
5
Heart failure and mechanical circulatory assist devices.心力衰竭与机械循环辅助装置
Glob J Health Sci. 2013 May 14;5(5):11-9. doi: 10.5539/gjhs.v5n5p11.
6
Ventricular assist devices: history, patient selection, and timing of therapy.心室辅助装置:历史、患者选择和治疗时机。
J Cardiovasc Transl Res. 2009 Jun;2(2):159-67. doi: 10.1007/s12265-009-9098-5. Epub 2009 Mar 19.
7
Physiologic and pathologic changes in patients with continuous-flow ventricular assist devices.连续性血流心室辅助装置患者的生理和病理变化。
J Cardiovasc Transl Res. 2009 Jun;2(2):154-8. doi: 10.1007/s12265-009-9092-y. Epub 2009 Mar 4.
8
Emerging ventricular assist devices for long-term cardiac support.新兴的心室辅助装置用于长期心脏支持。
Nat Rev Cardiol. 2010 Feb;7(2):71-6. doi: 10.1038/nrcardio.2009.222. Epub 2010 Jan 12.
9
Current status of cardiac transplantation and mechanical circulatory support.心脏移植与机械循环支持的现状
Curr Heart Fail Rep. 2009 Mar;6(1):28-33. doi: 10.1007/s11897-009-0006-8.